04/06/2012
Federal Register Notice: FDA is issuing an order under the Federal Food, Drug, and Cosmetic Act debarring Jyotin Parikh for five y...04/06/2012
Federal Register Notice: FDA is making available, Guidance for Industry and Food and Drug Administration Staff; User Fees for 513(...04/06/2012
Federal Register Notice: FDA is making available, Guidance for Industry and Food and Drug Administration Staff; FDA and Industry P...04/06/2012
Federal Register Notice: FDA has determined the regulatory review period for Takeda Pharmaceutical’s Teflaro is 2,118 days f...04/06/2012
Federal Register Notice: FDA has determined the regulatory review period is 3,602 days for Dainippon Sumitomo Pharma Co.’s L...04/06/2012
Federal Register Notice: FDA has determined the regulatory review period for Eli Lilly’s Natroba (spinosad) is 2,261 days fo...04/06/2012
Federal Register Notice: FDA has determined the regulatory review period for GE Healthcare Ltd.’s Datscan (Ioflupane I-123 i...04/06/2012
Federal Register Notice: FDA has determined the regulatory review period for Merck’s Viibryd (vilazodone hydrochloride) is 4...